Healthcare & life sciences coverage

chapter 11 and restructuring coverage across Healthcare & life sciences.

108 articles

Showing 97 to 108 of 108 coverage articles

Week of February 2, 2026

Red River Talc: $9B Talc Trust Plan Dismissed

Red River Talc, J&J's third talc bankruptcy, proposed a prepackaged $9B 524(g) trust for ~90,000 ovarian cancer claims in S.D. Texas. Filed Sept. 20, 2024, the case was dismissed March 31, 2025 for impermissible third-party releases, infeasible channeling structure, and voting defects.

PrepackagedHealthcare & life sciences

Week of January 26, 2026

Jan 26

ProSomnus: $27M Secured Debt Cut in 90-Day Plan

ProSomnus, Inc. filed chapter 11 in May 2024 after its 2022 de-SPAC listing left it overleveraged. A $13M DIP facility and prenegotiated plan confirmed in 90 days cut secured debt by ~65%, converting notes to equity while paying all trade creditors in full.

PrenegotiatedHealthcare & life sciences

Jan 26

White Rock Medical Center Files Chapter 11, Citing $11M Acquisition Dispute

White Rock Medical Center, a 218-bed Dallas safety-net hospital, filed chapter 11 on January 20, 2026 in SDTX. Management alleges Pipeline Health overstated receivables by over $11M at the time of the 2023 acquisition. An equipment 363 sale process is underway.

FreefallHealthcare & life sciences

Week of January 12, 2026

Jan 17

CarePoint Health: $67M DIP and Confirmed Plan Transfers NJ Hospitals

CarePoint Health filed chapter 11 Nov. 2024 in Delaware (case 24-12534) with $67M in DIP financing for its three Hudson County hospitals. A confirmed plan (Apr. 17, 2025) transferred the hospitals to Hudson Regional Health effective May 2025, with a Litigation Trust projecting 1%-2% GUC recovery.

FreefallHealthcare & life sciences

Week of January 5, 2026

Jan 10

Rite Aid: $4B Debt and Complete Liquidation After Two Filings

Rite Aid filed chapter 11 in October 2023 with $4 billion in funded debt and more than 1,600 opioid lawsuits. After emerging in September 2024 with $2 billion in debt eliminated, the pharmacy chain filed again in May 2025 and liquidated completely, closing all stores by October 2025.

FreefallConsumer & retail

Jan 7

Whitehall Trust: $31.3M Mortgage and Receiver Dispute Drive Chapter 11

Whitehall Trust and three PA senior care entities filed chapter 11 in December 2025 after a state court voided amended leases and ordered revenue turnover. The case involves $31.3M in mortgage debt and disputes over SARE status, cash collateral, and patient care oversight.

FreefallHealthcare & life sciences

Week of December 29, 2025

Jan 3

WeightWatchers: $1.15B Debt Cut in 42-Day Prepackaged Plan

WeightWatchers filed prepackaged chapter 11 in Delaware on May 6, 2025, after GLP-1 weight loss drugs undercut its subscription model. The 42-day case eliminated $1.15B of $1.6B in debt; the company emerged as a private entity on June 24, 2025.

PrepackagedConsumer & retail

Jan 3

Viridos Sells Algae Assets to Breakthrough Energy Ventures for $5.95M

Viridos’s algae-biofuel assets sold to Breakthrough Energy Ventures II for a $5.95M credit bid after its Delaware chapter 11 filing. The case was dismissed in November 2025.

Subchapter VHealthcare & life sciences

Jan 2

Perceptive Takes Synthego’s CRISPR Assets in $85M Credit Bid

Perceptive acquired Synthego’s CRISPR assets in an $85M credit bid. The confirmed liquidating plan estimated a 4.4% recovery for general unsecured creditors.

Healthcare & life sciences

Jan 1

The Villages Health's $538M Medicare Settlement Anchors Liquidating Plan

The Villages Health's chapter 11 turned on a Medicare coding program that made the U.S. its largest creditor. After selling its primary care centers to CenterWell for $68M, the provider settled the government claim at $538.3M and reached an $80M developer settlement to fund a liquidating plan.

Healthcare & life sciences

Jan 1

SpiriTrust Lutheran: 80-Year Senior Care Provider Pursues 363 Sale

SpiriTrust Lutheran, 80-year nonprofit CCRC with 6,400 residents, filed chapter 11. $83.3M M&T Bank debt; LSMNJ stalking horse for 363 sale.

Healthcare & life sciences

Week of March 3, 2025

Mar 6

Vyera Pharmaceuticals: Daraprim Legacy Ends in Liquidation

Vyera Pharmaceuticals, the company behind the infamous Daraprim price hike by Martin Shkreli, filed Subchapter V bankruptcy in Delaware in May 2023. The confirmed plan created a dual-track liquidating trust structure with creditor recoveries contingent on an orphan drug Priority Review Voucher.

Subchapter VHealthcare & life sciences